Sam Watson founded Bioxyne, an ASX-listed alternative health company.
Final investment decisions pushed back to 2026 because of complexity.
It’s been nearly a month since the Aussie dairy company filed for one.
OTM spots some rates-capping hypocrisy, as well as corporate moans about leaks.